When antivirals backfire: An evaluation of favipiravir's clinical outcomes in critically ill patients with COVID-19: A multicenter cohort study.

Background: Favipiravir is an oral antiviral, that might treat COVID-19 by enhancing viral eradication, particularly in patients with mild-to-moderate disease. Yet, the findings on the use of favipiravir in critically ill patients with COVID-19 are inconsistent. Therefore, this study aimed to assess the effectiveness and safety of favipiravir in critically ill patients with COVID-19.

Preparation and Characterization of Modified Polysulfone with Crosslinked Chitosan-Glutaraldehyde MWCNT Nanofiltration Membranes, and Evaluation of Their Capability for Salt Rejection.

Nanofiltration membranes were successfully created using multi-walled carbon nanotubes (MWCNTs) and MWCNTs modified with amine (MWCNT-NH2) and carboxylic groups (MWCNT-COOH). Chitosan (CHIT) and chitosan−glutaraldehyde (CHIT-G) were utilized as dispersants. Sonication, SEM, and contact angle were used to characterize the as-prepared membranes.